CV Sciences (CVSI) Cash from Investing Activities (2013 - 2026)
CV Sciences' (CVSI) quarterly Cash from Investing Activities came in at -$3000.0 in Q1 2026, up 92.5% year-on-year from -$1558.4 in Q1 2025, and up 66.67% quarter-over-quarter from -$9000.0 in Q4 2025.
CV Sciences (CVSI) Cash from Investing Activities (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Cash from Investing Activities across 13 years of filings, most recently posting -$3000.0 for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$3000.0, up 92.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$72000.0 (down 5.88% YoY), and the FY2025 annual result was -$109000.0, down 289.29% from the prior year.
- Cash from Investing Activities came in at -$3000.0 for Q1 2026 at CV Sciences, up from -$9000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $34000.0 in Q3 2024 to a low of -$156000.0 in Q4 2023.
- The 4-year median for Cash from Investing Activities is -$22000.0 (2024), against an average of -$32888.9.
- Across the five-year window, Cash from Investing Activities plunged 132.35% in 2025 and jumped 92.5% in 2026, its largest moves.
- CV Sciences' Cash from Investing Activities stood at -$156000.0 in 2023, then surged by 85.9% to -$22000.0 in 2024, then soared by 59.09% to -$9000.0 in 2025, then jumped by 66.67% to -$3000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$3000.0 (Q1 2026), -$9000.0 (Q4 2025), and -$11000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -22,000.00 |
| Dec 31, 2024 | -22,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Dec 31, 2023 | -156,000.00 |
| Dec 31, 2023 | -156,000.00 |
| Mar 31, 2021 | -35,000.00 |
| Mar 31, 2021 | -35,000.00 |